Theratechnologies Inc. (THTX)
Theratechnologies Statistics
Share Statistics
Theratechnologies has 45.98M shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 45.98M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 0.06% |
| Shares Floating | 36.29M |
| Failed to Deliver (FTD) Shares | 1.94K |
| FTD / Avg. Volume | 0.07% |
Short Selling Information
The latest short interest is 1.19M, so 2.58% of the outstanding shares have been sold short.
| Short Interest | 1.19M |
| Short % of Shares Out | 2.58% |
| Short % of Float | 3.77% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -7.19 and the forward PE ratio is 12. Theratechnologies's PEG ratio is 0.09.
| PE Ratio | -7.19 |
| Forward PE | 12 |
| PS Ratio | 0.7 |
| Forward PS | 0.9 |
| PB Ratio | -2.36 |
| P/FCF Ratio | 67.95 |
| PEG Ratio | 0.09 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Theratechnologies.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.19, with a Debt / Equity ratio of -1.8.
| Current Ratio | 1.19 |
| Quick Ratio | 1.05 |
| Debt / Equity | -1.8 |
| Debt / EBITDA | 6.63 |
| Debt / FCF | 51.88 |
| Interest Coverage | 0.78 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $833.65K |
| Profits Per Employee | $-80.64K |
| Employee Count | 103 |
| Asset Turnover | 1.61 |
| Inventory Turnover | 3.87 |
Taxes
| Income Tax | 2M |
| Effective Tax Rate | -31.82% |
Stock Price Statistics
The stock price has increased by 92.37% in the last 52 weeks. The beta is 1.5, so Theratechnologies's price volatility has been higher than the market average.
| Beta | 1.5 |
| 52-Week Price Change | 92.37% |
| 50-Day Moving Average | 1.69 |
| 200-Day Moving Average | 1.48 |
| Relative Strength Index (RSI) | 68.86 |
| Average Volume (20 Days) | 2.98M |
Income Statement
In the last 12 months, Theratechnologies had revenue of 85.87M and earned -8.31M in profits. Earnings per share was -0.17.
| Revenue | 85.87M |
| Gross Profit | 65.42M |
| Operating Income | 8.17M |
| Net Income | -8.31M |
| EBITDA | 6.88M |
| EBIT | 4.12M |
| Earnings Per Share (EPS) | -0.17 |
Balance Sheet
The company has 5.9M in cash and 45.61M in debt, giving a net cash position of -39.71M.
| Cash & Cash Equivalents | 5.9M |
| Total Debt | 45.61M |
| Net Cash | -39.71M |
| Retained Earnings | -416.89M |
| Total Assets | 53.34M |
| Working Capital | 7.12M |
Cash Flow
In the last 12 months, operating cash flow was 2.38M and capital expenditures -1.5M, giving a free cash flow of 879K.
| Operating Cash Flow | 2.38M |
| Capital Expenditures | -1.5M |
| Free Cash Flow | 879K |
| FCF Per Share | 0.02 |
Margins
Gross margin is 76.19%, with operating and profit margins of 9.52% and -9.67%.
| Gross Margin | 76.19% |
| Operating Margin | 9.52% |
| Pretax Margin | -7.34% |
| Profit Margin | -9.67% |
| EBITDA Margin | 8.01% |
| EBIT Margin | 9.52% |
| FCF Margin | 1.02% |
Dividends & Yields
THTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for THTX.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Jul 31, 2023. It was a backward split with a ratio of 1:4.
| Last Split Date | Jul 31, 2023 |
| Split Type | backward |
| Split Ratio | 1:4 |
Scores
| Altman Z-Score | -8.07 |
| Piotroski F-Score | 4 |